June 2019

In May, Discern Health Director Theresa Schmidt moderated two panels that built on the discussion presented in the National Pharmaceutical Council (NPC) and Discern white paper, Improving Patient-reported Measures in Oncology.

The panels at the annual meetings of the Pharmacy Quality Alliance (PQA) and the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) discussed gaps in patient-reported measures (PRMs) in oncology and examined controversies on this topic from multiple perspectives. PRMs are tools, such as surveys, that capture patients’ voices related to their care. Patient-reported performance measures (PR-PMs) translate PRM responses into metrics that can be used to assess provider performance, compare entities, and measure changes over time.

Read summaries of the PQA and ISPOR conference presentations here.

For more information, please contact Theresa Schmidt at tschmidt@discernhealth.com.